Haleon PLC
Research Haleon PLC (H6D0) on Bullrun: market cap EUR 36.86B, P/E 19.9, dividend yield 1.3%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerH6D0
- ExchangeHM
- CountryUnited Kingdom
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- CurrencyEUR
- Market capEUR 36.86B
- P/E19.9
- Dividend yield1.3%
- Financial periodFY2025
- RevenueGBP 11.03B
- Revenue growth-1.8%
- Net incomeGBP 1.68B
- Free cash flowGBP 2.31B
- Gross margin64.2%
Valuation Snapshot
latest market cap is EUR 36.86B; P/E is 19.9; dividend yield is 1.3%.
Peer valuation comparison
Latest P/E is 19.93x versus a Healthcare sector median of 24.46x (18.5% below).
Latest dividend yield is 1.32% versus a Healthcare sector median of 2.11% (37.4% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | GBP 11.03B | GBP 1.68B | GBP 2.31B | 64.2% | 0.19 | GBP 1.32B | GBP 7.77B | GBP 16.43B |
| FY2024 | GBP 11.23B | GBP 1.48B | GBP 2.05B | 60.7% | 0.16 | GBP 2.25B | GBP 8.64B | GBP 16.17B |
| FY2023 | GBP 11.30B | GBP 1.11B | GBP 1.87B | 59.7% | 0.11 | GBP 1.04B | GBP 8.80B | GBP 16.73B |
| FY2022 | GBP 10.86B | GBP 1.12B | GBP 1.76B | 60.6% | 0.12 | GBP 684.00M | GBP 10.00B | GBP 16.46B |
| FY2021 | GBP 9.55B | GBP 1.44B | GBP 1.13B | 62.3% | 0.15 | GBP 414.00M | GBP 87.00M | GBP 26.48B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-15 | EUR 36.86B | 19.9 | 2.0% | 0.08 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.08 EUR, yield 1.3%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.08 GBP |
| FY2024 | 0.07 GBP |
| FY2023 | 0.05 GBP |
About Haleon PLC
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Haleon PLC's market cap?
Haleon PLC's market capitalization is EUR 36.86B.
What is Haleon PLC's P/E ratio?
Haleon PLC's price-to-earnings (P/E) ratio is 19.9.
Does Haleon PLC pay a dividend?
Haleon PLC has a dividend yield of 1.3%.
What does Haleon PLC do?
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.